Lipids play crucial roles in the susceptibility and brain cellular responses to Alzheimer's
disease (AD) and are increasingly considered potential soluble biomarkers in cerebrospinal …

Lipid dysregulations have been critically implicated in Alzheimer's disease (AD) pathology.
Chemical analysis of amyloid-β (Aβ) plaque pathology in transgenic AD mouse models has …

Lipids are key regulators of brain function and have been increasingly implicated in
neurodegenerative disorders including Alzheimer disease (AD). Here, a systems-based …

Alzheimer's disease (AD) is reported to be closely linked with abnormal lipid metabolism. To
gain a more comprehensive understanding of what causes AD and its subsequent …

Alzheimer's disease (AD) affects one in eight individuals over 65 and poses an immense
societal challenge. AD pathology is characterized by the formation of beta‐amyloid plaques …

Alzheimer's disease (AD) is reported to be closely linked with abnormal lipid metabolism. To
gain a more comprehensive understanding of what causes AD and its subsequent …

The brain is highly enriched in lipids, and an intensive study of these lipids may be
informative, not only of normal brain function but also of changes with age and in disease. In …

Amyloid plaque formation constitutes one of the main pathological hallmarks of Alzheimer's
disease (AD) and is suggested to be a critical factor driving disease pathogenesis …

Understanding of Alzheimer's disease (AD) pathophysiology requires molecular assessment
of how key pathological factors, specifically amyloid β (Aβ) plaques, influence the …

Over the last 10 years, considerable technical advances in mass spectrometry (MS)‐based
bioanalysis have enabled the investigation of lipid signatures in neuropathological …